Seroquel vs. Vraylar
See how Seroquel and Vraylar compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Seroquel and Vraylar are both atypical antipsychotics approved for schizophrenia and bipolar disorder, but they differ in dosing schedule, side effects, and price.
Seroquel is taken two to three times a day and tends to cause sedation and weight gain, while once-daily Vraylar is more likely to cause restlessness and movement-related side effects.
Seroquel is available as a low-cost generic, while Vraylar is brand-only and can cost roughly $1,500 to $2,100 a month without insurance.
Seroquel vs. Vraylar Drug Summary
Seroquel
Seroquel (quetiapine) is an atypical antipsychotic approved for schizophrenia, manic or mixed episodes of bipolar I disorder, and bipolar depression. It's taken by mouth, usually two to three times a day, with the dose increased gradually over the first several days of treatment.
Vraylar
Vraylar (cariprazine) is an atypical antipsychotic approved for schizophrenia, manic or mixed episodes of bipolar I disorder, bipolar depression, and as an add-on for major depressive disorder. It's taken by mouth once a day, with the dose increased after the first day based on response.
Seroquel vs. Vraylar Side Effects
Seroquel
Vraylar
Seroquel vs. Vraylar Dosage
Seroquel
Vraylar
| STAGE | DOSE | WHEN |
| Starting dose | 50 mg/day | Day 1 |
| Maximum dose | 150-750 mg/day | Day 5 onward |
| Dose changes | 4 increases | Every day |
| STAGE | DOSE | WHEN |
| Starting dose | 1.5 mg once daily | Day 1 |
| Maximum dose | 6 mg once daily | If needed |
| Dose changes | 3 increases | Every day |
Seroquel
| STAGE | DOSE | WHEN |
| Starting dose | 50 mg/day | Day 1 |
| Maximum dose | 150-750 mg/day | Day 5 onward |
| Dose changes | 4 increases | Every day |
Vraylar
| STAGE | DOSE | WHEN |
| Starting dose | 1.5 mg once daily | Day 1 |
| Maximum dose | 6 mg once daily | If needed |
| Dose changes | 3 increases | Every day |
Seroquel vs. Vraylar Indications
Seroquel
Seroquel is FDA-approved for schizophrenia in adults and adolescents, for manic or mixed episodes of bipolar I disorder, for depressive episodes of bipolar disorder, and as long-term add-on therapy for bipolar I maintenance. It is not approved on its own for major depressive disorder outside of bipolar illness.
Schizophrenia (adults and adolescents 13-17)
Acute manic or mixed episodes of bipolar I disorder
Depressive episodes of bipolar disorder
Maintenance treatment of bipolar I, as an add-on
Vraylar
Vraylar is FDA-approved for schizophrenia in adults and adolescents, for manic or mixed episodes of bipolar I disorder, for depressive episodes of bipolar I disorder, and as an add-on treatment for major depressive disorder in adults already taking an antidepressant.
Schizophrenia (adults and adolescents 13+)
Acute manic or mixed episodes of bipolar I disorder
Depressive episodes of bipolar I disorder
Add-on treatment for major depressive disorder
Seroquel vs. Vraylar Pros and Cons
Seroquel
Seroquel has decades of real-world use and is available as an inexpensive generic in many tablet strengths, which makes long-term treatment more affordable. Its main tradeoffs are sedation and weight gain, which can affect daily functioning and metabolic health.
Pros
Available as a low-cost generic (quetiapine)
Long track record of use, approved since 1997
Sedating effect can help with sleep and agitation
Wide range of tablet strengths for flexible dosing
Cons
Requires multiple daily doses for most indications
Higher risk of sedation and weight gain than some options
Needs a slower titration over several days at start
Not approved as a standalone MDD treatment
Vraylar
Vraylar's once-daily dosing and long half-life make it more forgiving of an occasional missed dose, and it carries a lower burden of sedation and weight gain in trials than many older antipsychotics. Its main tradeoffs are a higher rate of movement-related side effects and a brand-only price that can run roughly $1,500 to $2,100 a month without insurance.
Pros
Once-daily dosing simplifies the regimen
Lower rates of sedation and weight gain in trials
Long half-life buffers the effect of a missed dose
Approved as an add-on specifically for MDD
Cons
Higher rates of akathisia and movement-related effects
No generic yet; brand-only, roughly $1,500 to $2,100 per month without insurance
Full effect of a dose change can take weeks to show up
Newer drug with a shorter real-world track record
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.